Bioavailability Enhancement Delivery Composition
AssigneePruGen IP Holdings, Inc.
InventorBhiku G. Patel
Life of this patent
Estimating the term…
Abstract
A composition for increasing the bioavailability of an active pharmaceutical ingredient (“API”) in humans and animals, comprising a first water soluble surfactant having a cloud point greater than about 37° C., a second water soluble surfactant having a cloud point greater than about 37° C., wherein a mixture of the first surfactant and the second surfactant comprises a cloud point less than about 37° C.
Claims32
A composition for increasing the bioavailability of an active pharmaceutical ingredient (“API”) in humans and animals, comprising:
- a first water soluble surfactant having a cloud point greater than about 37° C.;
- a second water soluble surfactant having a cloud point greater than about 37° C.;
- wherein a mixture of said first surfactant and said second surfactant comprises a cloud point less than about 37° C.
A composition for increasing the bioavailability of an active pharmaceutical ingredient (“API”) in humans and animals, formed by the process of:
- mixing a first water soluble surfactant having a cloud point greater than about 37° C. with a second water soluble surfactant having a cloud point greater than about 37° C.;
- wherein the mixture of said first surfactant and said second surfactant comprises a cloud point less than about 37° C.
Dependencies are inferred from the claim text.